Trimetobenzamid

Trimetobenzamid
Klinički podaci
Prodajno imeAmetik hydrochloride, Benzacot, Nauseton, Stemetic
Drugs.comMonografija
Način primeneOralno, intramaskularno, rektalno
Farmakokinetički podaci
Poluvreme eliminacije7 - 9 h
Identifikatori
CAS broj138-56-7 ДаY
ATC kodNone
PubChemCID 5577
DrugBankDB00662 ДаY
ChemSpider5375 ДаY
KEGGC07178 ДаY
ChEMBLCHEMBL1201256 ДаY
Hemijski podaci
FormulaC21H28N2O5
Molarna masa388,457
SMILES
  • COC1=CC(=CC(OC)=C1OC)C(=O)NCC1=CC=C(OCCN(C)C)C=C1
InChI
  • InChI=1S/C21H28N2O5/c1-23(2)10-11-28-17-8-6-15(7-9-17)14-22-21(24)16-12-18(25-3)20(27-5)19(13-16)26-4/h6-9,12-13H,10-11,14H2,1-5H3,(H,22,24) ДаY
  • Key:FEZBIKUBAYAZIU-UHFFFAOYSA-N ДаY
Fizički podaci
Tačka topljenja1.887 °C (3.429 °F)

Trimetobenzamid je organsko jedinjenje, koje sadrži 21 atom ugljenika i ima molekulsku masu od 388,457 Da.[1][2]

Osobine

Osobina Vrednost
Broj akceptora vodonika 6
Broj donora vodonika 1
Broj rotacionih veza 10
Particioni koeficijent[3] (ALogP) 2,7
Rastvorljivost[4] (logS, log(mol/L)) -4,4
Polarna površina[5] (PSA, Å2) 69,3

Reference

  1. ^ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035—41. PMC 3013709 Слободан приступ. PMID 21059682. doi:10.1093/nar/gkq1126.  уреди
  2. ^ David S. Wishart; Craig Knox; An Chi Guo; Dean Cheng; Savita Shrivastava; Dan Tzur; Bijaya Gautam; Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic acids research. 36 (Database issue): D901—6. PMC 2238889 Слободан приступ. PMID 18048412. doi:10.1093/nar/gkm958.  уреди
  3. ^ Ghose, A.K.; Viswanadhan V.N. & Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A. 102: 3762—3772. doi:10.1021/jp980230o. 
  4. ^ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488—1493. PMID 11749573. doi:10.1021/ci000392t.  уреди
  5. ^ Ertl P.; Rohde B.; Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714—3717. PMID 11020286. doi:10.1021/jm000942e.  уреди

Literatura

  • Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803. 
  • Thomas L. Lemke; David A. Williams, ур. (2007). Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799. 

Spoljašnje veze

  • Portal Medicina
  • Portal Hemija
Trimetobenzamid na Vikimedijinoj ostavi.
  • Trimethobenzamide
  • p
  • r
  • u
5-HT3 AntagonistiCB1 Agonisti (Kanabinoidi)D2/D3 AntagonistiH1 Antagonisti (Antihistamini)mACh Antagonisti (Antiholini)q1 AntagonistiDrugi

M: DIG

anat(t, g, p)/phys/devp/enzy

noco/cong/tumr, sysi/epon

proc, drug(A2A/2B/3/4/5/6/7/14/16), blte